Alterola Biotech, Inc.
ABTI
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -602.90K | -654.70K | 490.80K | -2.01M | -407.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -196.30K | 306.60K | -90.80K | 113.90K | -118.80K |
| Change in Net Operating Assets | -61.40K | 140.90K | -473.60K | 720.60K | 18.20K |
| Cash from Operations | -860.60K | -207.20K | -73.60K | -1.18M | -508.40K |
| Capital Expenditure | -- | -- | -- | -- | 166.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.00K | -- | -- | -35.00K | 35.00K |
| Cash from Investing | -60.00K | -- | -- | -35.00K | 201.90K |
| Total Debt Issued | 1.36M | 1.18M | 680.00K | 498.60K | 290.30K |
| Total Debt Repaid | -1.06M | -- | -- | -- | 38.50K |
| Issuance of Common Stock | 0.00 | 200.00 | 44.10K | 715.40K | -- |
| Repurchase of Common Stock | -- | -- | -544.70K | -- | -214.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.90K | -260.00K | -- | -- | -- |
| Cash from Financing | 399.90K | 923.00K | 179.30K | 1.21M | 114.10K |
| Foreign Exchange rate Adjustments | -110.80K | -4.20K | -105.60K | -9.70K | 165.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -631.50K | 711.60K | 100.00 | -6.50K | -27.40K |